[Liver transplantation in children. Indications and results]

Area of Science:

• Pediatric Hepatology
• Transplant Surgery
• Immunology

Background:

• Liver diseases in children pose significant health challenges.
• Historically, pediatric liver disease outcomes were poor.
• Advances in medical and surgical fields were needed.

Purpose of the Study:

• To evaluate the impact of cyclosporine A and technical advancements on pediatric liver transplantation outcomes.
• To establish current survival rates and long-term quality of life post-transplant in children.
• To highlight the role of liver transplantation as a primary treatment for pediatric liver diseases.

Main Methods:

• Review of clinical data from pediatric liver transplant recipients.
• Analysis of survival rates at the 5-year post-transplant mark.
• Assessment of quality of life indicators in long-term survivors.
• Incorporation of immunosuppression protocols (cyclosporine A) and surgical techniques (reduced-size adult grafts).

Main Results:

• Significant improvement in pediatric liver transplant outcomes.
• Cyclosporine A use and technical innovations have been key factors.
• 5-year survival rates for transplanted children range from 70% to 80%.
• Transplanted children experience normal life post-transplant.

Conclusions:

• Liver transplantation is now a highly successful and established treatment for pediatric liver diseases.
• Improved immunosuppression and surgical techniques have revolutionized pediatric liver transplant care.
• The majority of children undergoing liver transplantation can expect a normal life expectancy.